Nicoline van Leersum

Nicoline van Leersum is the EMEA Precision Medicine Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson. She specializes in precision medicine, focusing on innovative approaches to healthcare that tailor treatments to individual patient needs. Her role involves leading initiatives that integrate advanced diagnostics and therapeutic strategies to improve patient outcomes across the Europe, Middle East, and Africa (EMEA) regions.

Background and Career

• Education and Early Career: Nicoline was born on July 27, 1984, in Zeist, Netherlands. She grew up in The Hague in a family with a strong medical background, which influenced her career path in healthcare.4
• Professional Experience: Before her current position, she held various roles within Janssen, including strategic leadership in medical affairs. Her expertise lies in bridging the gap between scientific innovation and clinical application, particularly in oncology and other complex diseases.35

Contributions and Initiatives

• Advocacy for Precision Medicine: Nicoline actively participates in discussions and events focused on precision oncology, emphasizing the importance of collaboration among healthcare professionals, patients, and regulatory bodies to overcome healthcare challenges.12
• Public Speaking: She has been a speaker at various industry events, sharing insights on the future of precision medicine and its impact on patient care.1

Nicoline van Leersum's work is pivotal in advancing personalized healthcare solutions that meet the unique needs of patients throughout the EMEA region.